Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03264898 · ClinicalTrials.gov registry record
Comparative Effectiveness of FITs With Colonoscopy
A clinical trial, sponsored by Barcey T. Levy.
- Completed
- Registry status
- 3,761
- Enrollment target
NCT03264898: Completed study, sponsored by Barcey T. Levy.
NCT03264898 is a clinical trial that has completed, run by Barcey T. Levy. The registered enrollment target is 3,761 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03264898 has completed, sponsored by Barcey T. Levy.
- COMPLETED
- Registry status
- 3,761 participants
- Enrollment target
Study Summary
Colorectal cancer is a preventable and/or a treatable cancer, but at least 43% of the United States population is not up-to-date with screening. Although 90% of colorectal cancer screening is done using colonoscopy, most other countries use fecal immunochemical tests, reserving colonoscopy for those with a positive fecal immunochemical test. This project will provide the foundation for a paradigm shift for colorectal cancer screening in the United States by identifying how well 5 different FITs work for detecting screening relevant neoplasia, thus reducing morbidity and mortality for colorectal cancer.
Interventions
- DEVICE Fecal immunochemical test (FIT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,761 participants |
| Start Date | 2017-10-02 |
| Est. Completion | 2023-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03264898
The ClinicalTrials.gov registry entry for NCT03264898 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,761 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Barcey T. Levy, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fecal immunochemical test (FIT) is the first listed.
NCT03264898 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03264898 about?
NCT03264898 is a clinical study titled "Comparative Effectiveness of FITs With Colonoscopy". Colorectal cancer is a preventable and/or a treatable cancer, but at least 43% of the United States population is not up-to-date with screening. Although 90% of colorectal cancer screening is done using colonoscopy, most other countries use fecal immunochemical tests, reserving colonoscopy for those...
What is the current status of trial NCT03264898?
This trial is currently completed. The enrollment target is 3,761 participants. The study started on 2017-10-02. Estimated completion is 2023-10-01.
What interventions are being tested in trial NCT03264898?
The interventions under investigation include: Fecal immunochemical test (FIT) (DEVICE).
Who is sponsoring clinical trial NCT03264898?
This trial is sponsored by Barcey T. Levy, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.